Click here to Vote! All Cr@king T00ls You Need
Start New Thread
Print this thread

Expert Opinion on Pharmacotherapy, 2008 February, Volume 9, Number 6

Expert Opinion on Pharmacotherapy, 2008 February, Volume 9, Number 6

Free Content:
Editorial
$ N+ d# B7 d; n# ]
3 A; ~6 h/ Q, ~6 k; S7 wThe failure of torcetrapib: is there a case for independent preclinical and clinical testing?
1 ?- E( U) p7 b. V# b6 W7 MSheila A Doggrell6 O  D1 |) A8 e6 C1 V
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 875-878.% e' ~5 \' U& E+ \- T

' G! D; D4 B  B0 ^  O1 NOriginal Research+ z% @0 I5 X  e0 h) a* e% U
0 g' o$ B& o# @# @1 ]5 _+ D
Pharmacokinetics of enteric-coated mycophenolate sodium: comparative study in patients with autoimmune disease and renal allograft
3 h/ ?' |& J5 w  O6 bIrmgard Neumann, Heinz Fuhrmann, Marina Kanzler, I-Fei Fang, Adelheid Jaeger, Helmut Graf, Peter Bayer, Josef Kovarik4 ^% M- A# @3 i0 ~# S  g
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 879-886.
- O" j+ E* i$ \
& _, c- u1 d9 YReviews
) Z$ J! c) B' a# H- F ! l' J7 \1 S# q0 a; M
Neuroprotectants in stroke therapy
3 o& y* X) j2 S3 l& r& hK Jeyaseelan, KY Lim, A Armugam
* F+ |: X- y9 r9 Y% F; WExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 887-900.+ G9 W  G- I! z; z

" p+ V; o; Z- l# f$ Y0 J: P4 f, yHaemorrhagic shock therapy
) G- D" @, Q. D6 K9 ~! B$ @! [Devashish J Anjaria, Alicia M Mohr, Edwin A Deitch6 o) H, Y9 A* T1 h8 Y  g+ G# N$ ~# V
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 901-911.
' M  w5 f2 B# `  M9 x 6 l$ ~7 Z) V1 c$ t  }
Pharmacotherapy of atrial fibrillation: an old option with new possibilities/ k: h/ ?3 o4 g) w6 ]$ f
Sabine Janko, Uwe Dorwarth, Ellen Hoffmann$ W) F# s) G. u/ [: A6 R
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 913-925.! {& d+ j; i" w8 s9 {1 _  j
( @7 U. a, e7 L3 D
Fungicidal versus Fungistatic: what's in a word?
! z' k0 R! p, X7 BJames S Lewis II, John R Graybill2 E4 e9 E( Z  g4 p! u" E
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 927-935.
4 d; v$ d9 L) x& X* D* `2 {' ` " J/ V- {' p7 ]" Q+ u# S
Pharmacotherapy of bone metastases in breast cancer patients
- X3 @. M$ V( R# @4 X! D/ h2 BBianca Petrut, Christine Simmons, Reuben Broom, Mateya Trinkaus, Mark Clemons, J0 g6 I# ]7 w
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 937-945.: \) a) k5 F7 b. m

% l; f3 m, B* L% n* t* r% }Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism
( j$ q& p, w( ]! c" T3 WMario Cozzolino, Diego Brancaccio
  c% ?2 u! X+ EExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 947-954.3 m  l- f; v0 O2 ^

! k" a$ H% _/ T" x) mPharmacotherapy of acne
' ?% A/ K( w0 ~6 x* I  I/ n6 ?% mKlaus Degitz, Falk Ochsendorf
4 l% g" e5 y" m- W9 w3 I- @8 AExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 955-971.
+ q  A7 i6 b% V  v: G4 ~ 7 U3 i$ g2 e" O  A0 v9 o0 O, Y" D
Therapeutic management of psychodermatological disorders' q& j; i; A( _7 J: f
Philip D Shenefelt
4 ?# P/ ]1 _& U8 H( A2 Z4 O0 WExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 973-985.. b, a! a: I, @, f2 J- `

7 O( ]! ]; u1 `  P+ B3 y, O0 `2 {Pharmacoeconomic Evaluation
- o! J. E( M& r2 M- }  r0 ? , [9 G! F) j& u- Z# C  \  S: s
Pharmacoeconomics of linezolid
' V- ~+ M4 r4 G1 l4 WSantiago Grau, Carlos Rubio-Terrés
* {+ H4 T0 m! D! i& `4 ~. h, Q  qExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 987-1000.! |9 ^2 ~6 B4 y6 R9 a
. o. A4 N- D  g3 n. S
Drug Evaluations
; j3 _# N4 ~0 Q3 v, M   P  l* D% l5 |7 C
A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future& D  F+ ?0 Q- O0 S' s
Lisa K Mannix
& k' ~. p% |! ]Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1001-1011.( W# m4 Z/ A0 }/ M  X

# T' M2 p8 q8 l+ SZoledronic acid for cancer therapy-induced and postmenopausal bone loss
7 U2 N* e- K6 kAdam M Brufsky. A6 F* {8 V. M  {- V" G
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1013-1028.
' h4 u5 r- h+ Q& }; @  a; P ! Y" B8 W% P' |" m. [$ T5 X3 ^
Homoharringtonine for the treatment of chronic myelogenous leukemia! y2 i& [" Z& u) z6 c1 q
Alfonso Quintás-Cardama, Jorge Cortes/ m( [) T9 n9 p+ B
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1029-1037.. Q6 M$ z6 c* ]5 J* r- a

1 O, C7 H% V0 C, q, zTibolone: the way to beat many a postmenopausal ailments6 v9 A9 G  O& X7 M# P* O$ Y# n! @
Gordana Lazovic, Ubavka Radivojevic, Jelena Marinkovic& L3 b" E* m" D+ M0 |
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1039-1047.& e" w6 ^( Z* L9 b- R1 J8 {
' @+ t5 z( o  J! h% B6 B4 s. {
MMX mesalamine: a novel high-dose, once-daily 5-aminosalicylate formulation for the treatment of ulcerative colitis
; C, ?3 P/ _7 WMary Y Hu, Mark A Peppercorn
- ?* X8 b2 d! A( Y8 O, p4 X! l1 EExpert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1049-1058.) q1 I& \+ q# t2 l6 X4 W8 Y
$ C) N2 F( f* C! @! N# d8 P  R# v
Travoprost/timolol fixed combination
9 k! K$ S, ]/ RMichael Herceg, Robert Noecker5 v3 N/ B5 R0 x/ Q2 \3 K
Expert Opinion on Pharmacotherapy, April 2008, Vol. 9, No. 6, Pages 1059-1065.
* B/ [+ [- F; v2 R/ P% q9 @
the hidden contents only visible for repliers

/ H; L7 [. z) n& B4 u4 i$ `( V+ O6 m
[ Last edited by blega at Apr 18, 2008 20:52 ]
the Last rate for this thread
  • admin Bandwidth +10 Excellent Comments Sep 04, 2008 17:38

TOP

I was not successfull in uploading the zip attachement.

TOP

Thank you very much

debemos compartir, gracias

TOP

thanks very much

TOP

thankssssssssssss

TOP

Thank you very much.. pls let me see...

TOP

thanks for sharing

TOP

Thank you very much..

TOP

Start New Thread